Takeda Pharmaceutical Co - ADR Live Stock Price Today, Share Analysis and Chart

Name: Takeda Pharmaceutical Co - ADR: Is Infosys Ltd. worth buying?
Item: Takeda Pharmaceutical Co - ADR
Rating: 2.354514
Author: Trendlyne DVM scores

Expensive Performer

about

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, whi...

14.76 0.11 (0.75%)

52W high on Sep 08, 2025

244.7K

XNYS Volume

XNYS 26 Sep, 2025 10:19 AM (EDT)

High Financial Strength

55.6 / 100

Expensive Valuation

30.0 / 100

Technically Neutral

47.3 / 100

Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

1Yr Price target upside is 23%

3 analysts

Takeda Pharmaceutical Co ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..